Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 487Liver Disease Diagnosis and TreatmentMetabolomics and Mass Spectrometry StudiesAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

Open access
Masoodi, Mojgan, Gastaldelli, Amalia, Hyötyläinen, Tuulia, Arretxe, Enara, Alonso, Cristina, Gaggini, Melania, Brosnan, Julia, Anstee, Quentin M., Millet, Oscar, Ortiz, Pablo, Mato, Jose M., Dufour, Jean-Francois, Orešič, Matej·2021·Nature Reviews Gastroenterology & Hepatology

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide and is often associated with aspects of metabolic syndrome. Despite its prevalence and the importance of early diagnosis, there is a lack of robustly validated biomarkers for diagnosis, prognosis and monitoring of disease progression in response to a given treatment. In this Review, we provide an overview of the contribution of metabolomics and lipidomics in clinical studies to identify biomarkers associated with NAFLD and nonalcoholic steatohepatitis (NASH). In addition, we highlight the key metabolic pathways in NAFLD and NASH that have been identified by metabolomics and lipidomics approaches and could potentially be used as biomarkers for non-invasive diagnostic tests. Overall, the studies demonstrated alterations in amino acid metabolism and several aspects of lipid metabolism including circulating fatty acids, triglycerides, phospholipids and bile acids. Although we report several studies that identified potential biomarkers, few have been validated.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41575-021-00502-9

Cites

195 of 195 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 195 references

Research works printed but not linked: 1

  1. Wolfe, R. R. & Chinkes, D. L. Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis (Wiley, 2004).

Cited by

See all 487

Metadata

Authors
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., Mato, J. M., Dufour, J.-F., & Orešič, M.
Affiliations
  • University Hospital of Bern (CH)
  • Istituto di Fisiologia Clinica (IT)
  • Örebro University (SE)
  • Euskadiko Parke Teknologikoa (ES)
  • Pfizer (United States) (US)
  • Newcastle University (GB)
  • Åbo Akademi University (FI)
Corresponding author
  • Masoodi, Mojgan
  • Orešič, Matej
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2021-09-10
Volume
18
Issue
12
Pages
835-856
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W3197814387
Cited by
451
References
195
Citations by year
2026: 69 · 2025: 104 · 2024: 109 · 2023: 95 · 2022: 70 · 2021: 4
FWCI
11.13
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, metabolomics, lipidomics, biomarkers, non-invasive diagnosis, amino acid metabolism, lipid metabolism, circulating fatty acids, triglycerides, phospholipids, bile acids, metabolic pathways, metabolic syndrome
MeSH terms
Lipidomics, Amino Acids, Bile Acids and Salts, Glutathione, Humans, Insulin Resistance, Prognosis, Biomarkers, Disease Progression, Glutamic Acid, Lipid Metabolism, Metabolomics, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. https://app.cochat.ai/papers/10.1038/s41575-021-00502-9
The paper
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., Mato, J. M., Dufour, J.-F., & Orešič, M. (2021). Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-021-00502-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.